These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 28196312

  • 1. Severe Venlafaxine Withdrawal Successfully Treated With a Short Course of Duloxetine.
    Cutler N.
    Prim Care Companion CNS Disord; 2017 Feb 09; 19(1):. PubMed ID: 28196312
    [No Abstract] [Full Text] [Related]

  • 2. First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.
    Lassen D, Ennis ZN, Damkier P.
    Basic Clin Pharmacol Toxicol; 2016 Jan 09; 118(1):32-6. PubMed ID: 26435496
    [Abstract] [Full Text] [Related]

  • 3. Venlafaxine-Induced Bruising: A Case Report.
    Carpenter JE, Fombi J, Udoka O, Holder-Perkins V.
    Prim Care Companion CNS Disord; 2016 Jan 09; 18(3):. PubMed ID: 27722026
    [No Abstract] [Full Text] [Related]

  • 4. Duloxetine lessens joint pain in early-stage breast cancer.
    Tanday S.
    Lancet Oncol; 2017 Jan 09; 18(1):e10. PubMed ID: 27989429
    [No Abstract] [Full Text] [Related]

  • 5. Venlafaxine induced akathisia: a case report.
    Ceylan ME, Evrensel A.
    Trends Psychiatry Psychother; 2016 Jan 09; 38(2):117. PubMed ID: 27409139
    [No Abstract] [Full Text] [Related]

  • 6. Differential inhibition of cardiac and neuronal Na(+) channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine.
    Stoetzer C, Papenberg B, Doll T, Völker M, Heineke J, Stoetzer M, Wegner F, Leffler A.
    Eur J Pharmacol; 2016 Jul 15; 783():1-10. PubMed ID: 27130441
    [Abstract] [Full Text] [Related]

  • 7. Comparative study of the effects of venlafaxine and duloxetine on chemotherapy-induced peripheral neuropathy.
    Farshchian N, Alavi A, Heydarheydari S, Moradian N.
    Cancer Chemother Pharmacol; 2018 Nov 15; 82(5):787-793. PubMed ID: 30105459
    [Abstract] [Full Text] [Related]

  • 8. Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay.
    Islin J, Munkboel CH, Styrishave B.
    Toxicol In Vitro; 2018 Mar 15; 47():63-71. PubMed ID: 29100959
    [Abstract] [Full Text] [Related]

  • 9. Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review.
    Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J.
    Psychother Psychosom; 2018 Mar 15; 87(4):195-203. PubMed ID: 30016772
    [Abstract] [Full Text] [Related]

  • 10. Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis.
    Renoux C, Lix LM, Patenaude V, Bresee LC, Paterson JM, Lafrance JP, Tamim H, Mahmud SM, Alsabbagh MW, Hemmelgarn B, Dormuth CR, Ernst P, Canadian Network of Observational Drug Effect Studies (CNODES) Investigators.
    Clin J Am Soc Nephrol; 2015 Oct 07; 10(10):1716-22. PubMed ID: 26231193
    [Abstract] [Full Text] [Related]

  • 11. A probable case of movement disorder (Tardive dyskinesia) due to duloxetine treatment.
    Yılmaz R, Üstün D, Tuncer Uzun S, Reisli R, Türk Ş.
    Agri; 2018 Oct 07; 30(4):199-201. PubMed ID: 30403275
    [Abstract] [Full Text] [Related]

  • 12. Prurigo successfully treated with duloxetine hydrochloride.
    Hashimoto T, Satoh T, Yokozeki H.
    Australas J Dermatol; 2019 Aug 07; 60(3):237-239. PubMed ID: 30675900
    [Abstract] [Full Text] [Related]

  • 13. Differences in the antinociceptive effects of serotonin-noradrenaline reuptake inhibitors via sodium channel blockade using the veratrine test in mice.
    Yoshizawa K, Suzuki Y, Nakamura T, Takahashi Y, Makino K, Takahashi H.
    Neuroreport; 2021 Jun 09; 32(9):797-802. PubMed ID: 33994525
    [Abstract] [Full Text] [Related]

  • 14. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo.
    Gao Y, Guo X, Han P, Li Q, Yang G, Qu S, Yue L, Wang CN, Skljarevski V, Dueñas H, Raskin J, Gu L.
    Int J Clin Pract; 2015 Sep 09; 69(9):957-66. PubMed ID: 25939897
    [Abstract] [Full Text] [Related]

  • 15. The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review.
    Bellantuono C, Vargas M, Mandarelli G, Nardi B, Martini MG.
    Hum Psychopharmacol; 2015 May 09; 30(3):143-51. PubMed ID: 25784291
    [Abstract] [Full Text] [Related]

  • 16. Venlafaxine-Associated Euprolactinemic Galactorrhea and Hypersexuality: A Case Report and Review of the Literature.
    Warren MB.
    J Clin Psychopharmacol; 2016 Aug 09; 36(4):399-400. PubMed ID: 27219091
    [No Abstract] [Full Text] [Related]

  • 17. Venlafaxine induced QTc interval prolongation in a therapeutic dose.
    Bavle A.
    Asian J Psychiatr; 2015 Aug 09; 16():63-4. PubMed ID: 26187237
    [Abstract] [Full Text] [Related]

  • 18. Serotonin Sensitivity and Withdrawal With Low-Dose Venlafaxine.
    Khan S, Sivananthan M, Bacon O.
    Prim Care Companion CNS Disord; 2019 Feb 28; 21(1):. PubMed ID: 30817861
    [No Abstract] [Full Text] [Related]

  • 19. Serotonin syndrome, rhabdomyolysis and convulsion associated with drug interaction between venlafaxine and amoxicillin/clavulanic acid.
    Fernández-Ferreiro A, Pose-Reino A, Martinez-Bahamonde F, Paris M, Guemas E, González-Barcia M, Lamas MJ.
    Actas Esp Psiquiatr; 2016 Sep 28; 44(5):193-202. PubMed ID: 27644102
    [No Abstract] [Full Text] [Related]

  • 20. Rhabdomyolysis With Acute Renal Failure Requiring Dialysis in McArdle Disease: A Role for the Antidepressant Venlafaxine?
    Torner S, Tinel C, Soltani Z, Rifle G, Mousson C.
    J Clin Psychopharmacol; 2016 Aug 28; 36(4):406-8. PubMed ID: 27300253
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.